ClinicalTrials.gg
Not yet recruitingNCT07862738Updated Oct 16, 2026

Inspiratory Muscle Training in Hospitalized Patients With Heart Failure Awaiting Advanced Therapies

An interventional study of POWERbreathe KH2 and Usual Care in Heart Failure, Heart Failure New York Heart Association Class III and Heart Failure New York Heart Association Class IV, sponsored by NYU Langone Health. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Treatment

How we know

Updated Oct 16, 2026Title changedNewly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Heart Failure by NYU Langone Health — 3 open to participants now, 3 under way, none of them phase 3. Heart Failure · NYU Langone Health.

Planned enrollment
10th of 14
30 · median 113
Started
2026
with 2 others
No phase
8 of 16
3 open now
Registered
16th of 16
by date

Among the 16 studies in Heart Failure by NYU Langone Health, this one is the 10th largest by planned enrollment of the 14 interventional ones that give a count, is one of 3 that started in 2026, is one of 8 with no phase, and was the 16th registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

3 of the 16 studies in Heart Failure by NYU Langone Health are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Heart Failure by NYU Langone Health, or all of them as a file.
02

Study summary

The primary objective of this study is to evaluate the feasibility and safety of inspiratory muscle training (IMT) when implemented as part of routine inpatient physical therapy care in patients undergoing evaluation for advanced heart therapies. The secondary aim is to determine if IMT improves 6-minute walk test (6MWT), dyspnea, Maximal Inspiratory Pressure (MIP) pre-operatively. Thirdly, to determine if IMT decreases ICU and hospital length of stay post-operatively.

Read the detailed description

This randomized prospective, pilot study will enroll 30 adults hospitalized with heart failure and awaiting advanced therapies (LVAD or Heart Transplant). One group will receive usual care PT while the intervention group will be instructed in the use of an inspiratory muscle trainer to be performed at least 5 days a week with the supervision of a physical therapist. Both groups will undergo testing of Maximal Inspiratory Pressure (MIP) using the POWERbreathe® Inspiratory Muscle Trainer. Data collection will include Maximal Inspiratory Pressure (MIP), 6-minute walk test (6MWT) distance, dyspnea at rest and with exertion, at the start, every two weeks from start, and end of study period.

03

Conditions studied

  • Heart Failure
  • Heart Failure New York Heart Association Class III
  • Heart Failure New York Heart Association Class IV

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 18 years old or older
  2. Able to provide consent and willing to participate in study procedures
  3. Currently hospitalized awaiting advanced therapies (LVAD or heart transplant)
  4. Diagnosed with class III or IV heart failure
  5. Able to follow instructions including the use of the Borg Dyspnea scale
  6. Physically able to independently hold and use the IMT
  7. Patients will undergo screening with or without active PT orders. To be enrolled in the study, patient must have an active physical therapy order. . If no active order exists, one will be requested from medical team following the screening and prior to enrollment.
  8. Participants must meet institutional criteria for participation in physical therapy and mobility activities prior to enrollment and before each IMT session. Medical stability may include:

    • Mean arterial pressure (MAP) ≥ 60 mmHg and ≤ 120 mmHg
    • Resting heart rate between 40 and 140 beats per minute
    • No evidence of active myocardial ischemia or unstable angina
    • No uncontrolled atrial or ventricular arrhythmias
    • No escalating vasopressor or inotropic support at time of intervention
    • Oxygen saturation ≥ 94% on current oxygen support
    • Respiratory rate between 8 and 35 breaths per minute
    • Ability to follow simple commands and participate in study procedures
    • No acute neurologic, respiratory, or hemodynamic deterioration requiring immediate escalation of care
    • Clearance by the treating medical team to participate in rehabilitation activities

Exclusion criteria

Exclusion Criteria:

  1. Patients discharged from the hospital to await advanced therapies (LVAD or heart transplant)
  2. Patients with an expectedpreoperative inpatient hospital stay of less than 10 days, based onreview of clinical status, treatment plan, and timing of expected surgery
  3. Patients with acute pneumothorax
  4. Presence of acute rib fracture(s)
  5. Patients with acute cerebrovascular accident
  6. Untreated hypertension, defined as systolic blood pressure consistently >140 mmHg or diastolic blood pressure consistently >90 mmHg in the absence of antihypertensive therapy.
  7. Acute delirium
  8. Perforated tympanic membrane
  9. Hemodynamic instability
  10. Abdominal surgery during present admission
  11. Patients with planned multiple organ transplant (e.g. heart and kidney, heart and lung)
  12. Patients currently requiring mechanical ventilatory support
  13. A burst eardrum that has not fully healed, or any other condition of the eardrum
  14. Patients with asthma who suffer from frequent severe exacerbations
  15. Patients with marked elevated left ventricular end-diastolic volume and pressure
  16. Patients with worsening heart failure signs and symptoms after IMT
  17. If you have suffered from or are likely to suffer from costochondritis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Inspiratory Muscle Training (IMT) + Usual Care

    Participants will perform IMT 1 set of 30 breaths at 50% MIP, 5 days/week, in addition to usual care physical therapy.

    Device: POWERbreathe KH2 · Other: Usual Care

  • Active comparator
    Usual Care Only

    Participants in this arm will receive usual care physical therapy only.

    Other: Usual Care

Interventions

  • DevicePOWERbreathe KH2

    IMT is a noninvasive, exercise-based intervention designed to improve inspiratory muscle strength and endurance by providing a resistive load during inhalation.

  • OtherUsual Care

    Usual care physical therapy may include functional mobility training, therapeutic activities, gait training, and therapeutic exercise, delivered according to the treating physical therapist's clinical judgment and the patient's medical status.

06

What researchers measure

Primary outcomes

  1. Percentage of completed training session

    Time frame: Final Visit (up to 6 months)

  2. Time required to administer and monitor IMT sessions

    Time frame: Final Visit (up to 6 months)

  3. Number of left ventricular assist device (LVAD) implantation or heart transplantation

    Time frame: Final Visit (up to 6 months)

Secondary outcomes

  1. Change in Six-Minute Walk Test (6MWT) in meters

    The 6MWT measures the total distance in meters that a person can walk on a flat, hard surface over a period of 6 minutes to evaluate functional exercise capacity. The primary score is the total distance walked in meters. Healthy adults typically walk between 400 and 700 meters.

    Time frame: Baseline, Post-operative

  2. Change in Borg Category-Ratio (CR) 10 Dyspnea Scale at rest

    The Borg CR10 Dyspnea Scale is a numerical rating tool that patients use to report how difficult their breathing feels at a specific moment. The scale ranges from 0 (Nothing at all) to 10 (Maximal (the worst breathing difficulty the person has ever experienced)).

    Time frame: Baseline, Final Visit (up to 6 months)

  3. Change in Borg CR10 Dyspnea Scale following exertion

    The Borg CR10 Dyspnea Scale is a numerical rating tool that patients use to report how difficult their breathing feels at a specific moment. The scale ranges from 0 (Nothing at all) to 10 (Maximal (the worst breathing difficulty the person has ever experienced)).

    Time frame: Baseline, Final Visit (up to 6 months)

  4. Change in maximal inspiratory pressure (MIP)

    MIP measures the strength of your breathing muscles, like the diaphragm and ribs. MIP values are recorded in centimeters of water (cmH₂O) as negative numbers. Note: Because it measures negative pressure, a larger negative number means stronger muscles

    Time frame: Baseline, Final Visit (up to 6 months)

  5. Post-operative ICU length of stay (LOS)

    Time frame: From post-operative admission until discharge (up to 4 weeks)

  6. Post-operative hospital LOS

    Time frame: From post-operative admission until discharge (up to 4 weeks)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Requests should be directed to: Angela.stolfi@nyulangone.org. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.

Access criteria: The investigator who proposed to use the data will be granted access reasonable request. Requests should be directed to Angela.stolfi@nyulangone.org. To gain access, data requestors will need to sign a data access agreement. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's DSSB.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for May 2027, 6 months later.

Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 6 months is below that.

Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2026
First posted
Oct 7, 2026
StartEst.
Nov 10, 2026
Primary completionEst.
May 10, 2027
CompletionEst.
Nov 10, 2027
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Title
Inspiratory Muscle Training in Hospitalized Patients With Heart Failure Awaiting Advanced Therapies: a Single-center Pilot Feasibility Study
Oct 16, 2026
Registered
First appeared on the registry
Oct 7, 2026
Show all 2 updates
  1. Oct 16, 2026
    Title Inspiratory Muscle Training in Hospitalized Patients With Heart Failure Awaiting Advanced Therapies: a Single-center Pilot Feasibility Study
  2. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07862738
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
Oct 7, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
May 10, 2027 (estimated)
Completion
Nov 10, 2027 (estimated)
Last update
Oct 16, 2026

Study contacts

Angela Stolfi, PT, DPT
Contact
Angela.stolfi@nyulangone.org
212-263-6074
Corinne Natale
Contact
Corinne.natale@nyulangone.org
212-263-6074
Angela Stolfi, PT, DPT
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion